Field Note Nº 02
Field Note Nº 02 · Singapore · July 2026

The New Consumer Tens of millions of people are quietly changing shape. Build for who they are becoming.

Bought Eli Lilly stock last month. The trigger was retatrutide, their triple agonist, which just posted over 30% average weight loss in Phase 3. Not a bet on the drug. A bet on the person the drug creates.

Subject
GLP-1s and the lifestyle economy
Market
Singapore & Southeast Asia
Sector
Hospitality, F&B, wellness
Date
July 2026
01

This One
Does Not Fail

Someone who loses a third of their body weight does not just buy smaller clothes. They rebuild their entire week. Where they go, what they eat, who they see, what they drink.

Multiply that by tens of millions of people and you are not looking at a pharma story. You are looking at a new consumer.

Twenty years working across nightlife, hospitality and fitness in this region, and for the first time, the way I think about the direction mass market consumption is going in this space has taken a dramatic shift. Below is why.

Diets fail. That is exactly why food and beverage survived every one of them. Atkins, keto, 5:2. The industry waited them out, because the customer always came back.

This one does not fail.

The Base Rate

Not a fad with a churn rate. A habit with a refill.

13.1%
Of US adults on a GLP-1 as of June 2026
1/5
US households with a user in them
54%
On it more than a year, up from 38% in 2024
30%
Average weight loss, retatrutide Phase 3, at two years

And the science is compounding. Eli Lilly is not one drug, it is a production line.

Mounjaro was the injection. In April, orforglipron was approved. A pill. Small molecule, mass manufacturable, no cold chain, no needle. Every barrier to adoption just got smaller. Retatrutide is next, the triple agonist, and the strongest Phase 3 numbers the class has produced. Novo is right behind with CagriSema and an amylin molecule showing 22% with no clear plateau.

Each generation is stronger, cheaper and easier to take than the last.

Nobody in hospitality is planning for a curve that keeps bending.

Being at a healthy weight stops being an achievement and starts being a baseline. First in the US, then everywhere that can afford it. Singapore will be early. It always is.

And it stops being about the drug fast. Millions of people are now getting visible results, and people with results make content. The volume of fitness, protein, training and recovery content in the feed goes up, and more content means more shots at virality, which means more of it lands in front of the masses.

The behaviour spreads faster than the prescription does, and we're just starting off.

02

Spending Is
Already Moving

Nobody stopped spending. They started spending on a different person.

Alani Nu Zero-sugar energy
nearly 2×
Cava Protein-led bowls, US
+22.5%
Non-alcoholic beer US dollar sales
+22.1%
Energy drinks Total category
+14%
Low-calorie soda
+11%
Jerky
+7.9%
Greek yoghurt
+6.8%
Snacks & confectionery
−12.4%

And they are getting better at this, fast. The hard part was never willpower. It was the admin. What to eat, how much protein, what to buy, how to prep it on a Sunday, what to order off a menu not built for you, what to change when the weight stalls. That used to take a nutritionist and a level of discipline most people do not have. Now it takes a phone, and they photograph a plate to get a number back.

Adherence was always the weak link in weight management. AI just went after it directly, and it gets easier every month.

03

Excess Is Dying
A Quick Death

Bottle service at Filter Members Club, Singapore

Champagne trains. Tables stacked with shared dishes at supper. Free flow. Supersize. Buy one get one free.

Thirty years of hospitality promotion has been a variation on the word more, and more is exactly what this customer has been medicated out of wanting.

Casual drinking is the casualty. Not drinking. The Tuesday pint, the third round nobody wanted, the after work session on autopilot. That volume goes, and it goes because people are either counting or have simply lost the urge. Give this three to five years of mainstream adoption and it will not be a segment behaviour. It will be the norm.

What survives is the confirmed good night. Birthdays, deals closed, stag nights, the night that actually means something.

Drinking becomes an occasion, not a default. Fine if you are the venue people choose for the occasion. Fatal if you are not.

Singapore cannot claim it was not warned. Wegovy has been approved here for weight management since 2023. Mounjaro is licensed and prescribable. Telehealth platforms have been writing scripts since last year. The customer is already here.

And the bars were already dying before any of it bit. Tippling Club closed after almost seventeen years. Smoke & Mirrors after nine. Jigger & Pony shut Sugarhall and Rosemead in the same month. Wine RVLT poured its last glass and reopened somewhere cheaper. All of it between the end of 2024 and last July. They mentioned rent, costs, and a crowd that stopped turning up.

The drug is not the fire. It is the accelerant, and the fire is already spreading.

04

Who Is Walking
In The Door

01
They count
Calories and protein, both. Every menu is scored against numbers they carry in their head, and most fail the test without knowing it
02
They drink, but only when it is worth it
Two good ones on a night that matters beats six average ones on a Tuesday. Your beverage margin was built on the six
03
Fewer visits, bigger tickets
Their money sits around the meal, not in it. The class before, the recovery after, the coffee, the kit
04
Many want to be seen
Years of declining invitations just ended. They are buying reasons to be looked at
05
They are buying permanence
The loss is done. What they pay for now is keeping it, and the routines that ensure it
06
Many are free agents
No tribe recruited them, no brand earned them, no gym or venue owns them. They want somewhere to belong
05

Surviving Without
Alcohol As The Engine

Two Singapore openings tell you where this is headed.

Foura opened at Gardens by the Bay this month. Blue Zone menu, a founder with a PhD in ageing, and the programme is yoga, breathwork, pilates, run clubs and sound baths. That is not a restaurant. It is a venue selling attendance rather than consumption, and dinner happens to be part of it.

Madison House opens at Fort Canning later this year. 37,000 square feet, four floors, a 3,200 square foot gym, cold plunge, sauna, and The Longevity Suite taking its first Asian site inside the club for cryotherapy and diagnostics. There is a members lounge and a whisky tasting programme, but read the order of it.

Longevity is the anchor tenant. The bar is a facility.

The room needs a reason to exist that isn't the drink. Take revenue from the class, the food, the retail, the membership, the recovery, and let beverage be a garnish on the P&L rather than the whole plate.

§ The Question

If your average guest orders one drink instead of six, eats half the plate and leaves at ten, are you still operating a viable business?

Most operators are not looking ahead. I'm writing this so you can see the changes in the landscape before it's too late.

Blue Root builds concepts around who they're for, then works backwards. If that's a conversation worth having, get in touch.

Sources

Disclosure: the author holds a personal position in Eli Lilly (LLY). Nothing in this note is financial advice.

John Langan
Founder · Blue Root Innovation Lab
Previous Field Note · Nº 01 Babel Socials: a premium gym full of people worth knowing, most walking straight past each other.